VENTYX BIOSCIENCES INC (VTYX) Stock Analyst Ratings
NASDAQ:VTYX - Nasdaq - US92332V1070 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to VTYX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is 660.25% above the current price.
VTYX was analyzed by 15 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VTYX.
In the previous month the buy percentage consensus was at a similar level.
VTYX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-08 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-12 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-03-12 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-21 | Oppenheimer | Reiterate | Perform |
| 2023-12-19 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-11-10 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-11-07 | Stifel | Downgrade | Buy -> Hold |
| 2023-11-07 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-11-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-10-10 | Stifel | Reiterate | Buy -> Buy |
| 2023-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-11 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-05 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-07-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |